cefuroxime has been researched along with Connective Tissue Diseases in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Słowińska, M | 1 |
Szymańska, E | 1 |
Walecka, I | 1 |
Rudnicka, L | 1 |
1 review available for cefuroxime and Connective Tissue Diseases
Article | Year |
---|---|
[Use of cefuroxime axetil in clinical practice].
Topics: Bacterial Infections; Borrelia Infections; Cefuroxime; Connective Tissue Diseases; Cytokines; Dermat | 2000 |